ClavystBio is a life sciences venture builder and investor established by Temasek to accelerate the commercialization of breakthroughs into health impact. It supports early-stage biotech, medtech, and digital health companies, focusing on areas like cell and gene therapy. ClavystBio offers investment, strategic partnerships, and collaborative infrastructure through its Node 1 innovation space. Its target audience includes innovators, entrepreneurs, and investors. The unique selling proposition is its integrated approach combining funding, partnerships, and infrastructure to foster global life sciences companies from Singapore, leveraging its strategic location and network.